Vontobel Holding’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.92M Buy
+27,400
New +$5.24M 0.02% 417
2025
Q3
Sell
-25,300
Closed -$3.18M 1355
2025
Q2
$3.18M Buy
+25,300
New +$3.15M 0.01% 438

Other funds holding BIIB

Vontobel Holding's BIIB Position: Q2 2026 in Review

Vontobel Holding increased its Biogen (BIIB) stake by 48% in Q2 2026, buying an estimated $1.26M and bringing the position to 20,311 shares worth $4.39M. The position accounts for 0.01% of the portfolio, ranked #474.

Vontobel Holding first reported a position in BIIB in Q4 2020 and has held it in 23 quarters since. The position peaked at $23.7M in Q4 2020. 1,045 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Vontobel Holding held 20,311 shares of Biogen worth $4.39M as of Q2 2026.
  • Vontobel Holding bought 6,601 Biogen shares in Q2 2026, an estimated $1.26M.
  • Biogen made up 0.01% of Vontobel Holding's portfolio in Q2 2026, its #474 holding.
  • Vontobel Holding first reported a position in Biogen in Q4 2020 and has held it in 23 quarters since.
  • Vontobel Holding's Biogen position peaked at $23.7M in Q4 2020.
  • 1,045 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.